Skip to main content
MRVI logo

MRVI · Maravai Lifesciences Holdings, Inc. · Analyst Estimates

Track MRVI — free
$7.45 +0.07 (+0.95%) Play latest call Q3 2026 earnings call transcript
Market Cap
$1.92B
Shares
259.94M
Volume · Nov 18 1.41M Avg daily vol (3M) 3.19M

Analyst Estimates

Compare analyst forecasts for Maravai Lifesciences Holdings, Inc. across metrics and forecast periods.

Estimates are grouped by forecast period, with low, average and high together. A dash means that statistic is not available.

Pull consensus estimates through the analyst estimates API or MCP →

Compiled consensus

These figures are a compiled consensus of analyst forecasts, not a survey the company published itself. Every figure is the statistic the source states; averages are means, never medians.

Captured 2026-11-16 06:26 UTC · Publication dates shown per estimate · 8 metric / period groups

FY ending 2026-12-31

Analyst estimates for FY ending 2026-12-31
Metric Low Average High Analyst count Average, 7 days ago Average, 30 days ago Average, 60 days ago Average, 90 days ago Estimates lowered, last 7 days Estimates lowered, last 30 days Estimates raised, last 7 days Estimates raised, last 30 days
EPS
USD
Publication date not stated
-0.095
-0.071
-0.05
9
-0.11
-0.11
-0.18
-0.18
0
0
1
1
Revenue
USD
Publication date not stated
212.50M
214.30M
215.20M
9
— — — — — — — —

FY ending 2027-12-31

Analyst estimates for FY ending 2027-12-31
Metric Low Average High Analyst count Average, 7 days ago Average, 30 days ago Average, 60 days ago Average, 90 days ago Estimates lowered, last 7 days Estimates lowered, last 30 days Estimates raised, last 7 days Estimates raised, last 30 days
EPS
USD
Publication date not stated
-0.15
-0.076
0.00
9
-0.10
-0.10
-0.11
-0.10
0
0
1
1
Revenue
USD
Publication date not stated
215.30M
224.56M
232.50M
9
— — — — — — — —

Q ending 2026-12-31

Analyst estimates for Q ending 2026-12-31
Metric Low Average High Analyst count Average, 7 days ago Average, 30 days ago Average, 60 days ago Average, 90 days ago Estimates lowered, last 7 days Estimates lowered, last 30 days Estimates raised, last 7 days Estimates raised, last 30 days
EPS
USD
Publication date not stated
-0.061
-0.039
-0.02
8
-0.044
-0.044
-0.082
-0.084
0
0
1
1
Revenue
USD
Publication date not stated
49.40M
51.18M
52.10M
9
— — — — — — — —

Q ending 2027-03-31

Analyst estimates for Q ending 2027-03-31
Metric Low Average High Analyst count Average, 7 days ago Average, 30 days ago Average, 60 days ago Average, 90 days ago Estimates lowered, last 7 days Estimates lowered, last 30 days Estimates raised, last 7 days Estimates raised, last 30 days
EPS
USD
Publication date not stated
0.00
0.008
0.02
4
-0.004
-0.004
-0.004
-0.004
0
0
0
0
Revenue
USD
Publication date not stated
54.20M
61.09M
70.00M
7
— — — — — — — —
Key facts CIK 1823239 CUSIP 56600D107 13F (30d) 217 filings 198 filers Visit website Investor relations